Latest SEC Filings

KULICKE & SOFFA INDUSTRIES INCKulicke and Soffa Reports 49.8% Revenue Increase and Net Income Recovery in Latest Quarter

AquaBounty Technologies, Inc.AquaBounty Technologies Reports $1.2 Million Net Loss in Q1 2026 Amid Strategic Changes

SILENCE THERAPEUTICS PLCSilence Therapeutics Reports Q1 2026 Revenue Growth to $422,000 Amid Continued Net Loss

Aurinia Pharmaceuticals Inc.Aurinia Pharmaceuticals Reports 24% Revenue Growth to $77.7 Million in Q1 2026

CRA INTERNATIONAL, INC.CRA International Reports 10.5% Revenue Growth but Declines in Net Income for Fiscal Quarter Ending April 4, 2026

International Seaways, Inc.International Seaways Reports 77% Revenue Growth to $325.5 Million in Latest Quarter

Harmony Biosciences Holdings, Inc.Harmony Biosciences Reports $215.4M Revenue and $32.5M Net Income in Q1 2026

Prime Medicine, Inc.Prime Medicine Reports Q1 2026 Financial Results with Decreased Revenue and Net Loss

Sabre CorpSabre Corporation Reports 8% Revenue Increase to $760.3 Million in Q1 2026

ACORN ENERGY, INC.Acorn Energy Reports 28.1% Revenue Decline in Q1 2026, Net Loss of $77,000

Kenvue Inc.Kenvue Inc. Reports 47.2% Increase in Net Income to $474 Million for Fiscal Quarter Ended March 29, 2026

Acadian Asset Management Inc.Acadian Asset Management Reports 39.2% Revenue Growth to $167M in Latest Quarter

Lantheus Holdings, Inc.Lantheus Holdings Reports $377.3 Million Revenue and $118.4 Million Net Income in Q1 2026

TerrAscend Corp.TerrAscend Reports $65.5 Million Revenue in Q1 2026, Net Loss Improves to $8 Million

ImmunityBio, Inc.ImmunityBio Reports 168% Revenue Growth to $44.2 Million Despite Increased Net Loss

COLLEGIUM PHARMACEUTICAL, INCCollegium Pharmaceutical Reports 9% Revenue Growth and Strategic Acquisition in Q1 2026

PSQ Holdings, Inc.PSQ Holdings Reports 167% Revenue Growth to $8.16 Million, Net Loss Increases to $6.45 Million

Advanced Flower Capital Inc.Advanced Flower Capital Inc. Reports 16% Increase in Investment Income for Q1 2026

Zura Bio LtdZura Bio Limited Reports $24.2 Million Net Loss in Q1 2026, Increases Liquidity to $225.6 Million

Vital Farms, Inc.Vital Farms Reports 15% Revenue Growth but Faces Net Loss and Increased Operating Expenses

Monte Rosa Therapeutics, Inc.Monte Rosa Therapeutics Reports Decrease in Revenue and Increased Net Loss in Latest 10-Q Filing

NCR VOYIX CorpNCR Voyix Reports $606 Million Revenue in Q1 2026, Net Loss Improves to $5 Million

Rapport Therapeutics, Inc.Rapport Therapeutics Reports $20 Million Collaboration Revenue in Q1 2026

Climb Bio, Inc.Climb Bio Reports Q1 2026 Financial Results with Improved Net Loss of $13.7 Million

Beam Therapeutics Inc.Beam Therapeutics Reports $31.7M Revenue Growth and $94.3M Net Loss for Q1 2026